Who invested in Aimmune Therapeutics?
Aimmune Therapeutics's investors include RA Capital Management, Fidelity, Foresite Capital, Longitude Capital and Adage Capital Management.
Who invested in Aimmune Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$200Mraised across 1 round since 2020, from 1 source
- Latest round
- Round, $200MFeb 2020
- Investors
- 5
The rounds
- Feb 2020Round$200M
Source recorded
Everyone who backed them
FidelityVC firm1round
Adage Capital ManagementAsset manager1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aimmune Therapeutics
How much has Aimmune Therapeutics raised?
Aimmune Therapeutics has raised $200M across 1 round since 2020.
When did Aimmune Therapeutics last raise?
Aimmune Therapeutics's most recent round was an Undisclosed round of $200M in Feb 2020.
What was Aimmune Therapeutics's biggest round?
Its most recent round, $200M in Feb 2020, is also its largest on record.
Who backed Aimmune Therapeutics first?
Aimmune Therapeutics's first round on record, in Feb 2020, was backed by RA Capital Management, Fidelity and Foresite Capital and 2 others.
What stage is Aimmune Therapeutics at?
Aimmune Therapeutics's latest named round is an Undisclosed round, in Feb 2020.
Companies like Aimmune Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.